Abstract | BACKGROUND:
Tramadol hydrochloride is a novel, centrally acting analgesic with two complementary mechanisms of action: opioid and aminergic. First marketed in 1994, tramadol is frequently prescribed by physicians for the management of moderate-to-moderately severe chronic pain. The author evaluates its unique analgesic pharmacology and limited clinical utility for managing acute pain in dentistry. TYPES OF STUDIES REVIEWED: Clinical drug trials in medicine and dentistry were reviewed to assess analgesic efficacy. Postmarketing surveillance studies and reports of adverse drug events were evaluated to determine short- and long-term safety. RESULTS: CLINICAL IMPLICATIONS:
Tramadol has limited indication for management of acute pain in dentistry, possibly as an alternative analgesic when gastrointestinal side effects contraindicate the use of nonsteroidal anti-inflammatory drugs and when codeine/ acetaminophen combination analgesics are not well-tolerated or are contraindicated.
|
Authors | P A Moore |
Journal | Journal of the American Dental Association (1939)
(J Am Dent Assoc)
Vol. 130
Issue 7
Pg. 1075-9
(Jul 1999)
ISSN: 0002-8177 [Print] England |
PMID | 10422401
(Publication Type: Journal Article, Review)
|
Chemical References |
- Adrenergic Uptake Inhibitors
- Analgesics, Non-Narcotic
- Analgesics, Opioid
- Anti-Inflammatory Agents, Non-Steroidal
- Drug Combinations
- Acetaminophen
- Tramadol
- Codeine
|
Topics |
- Acetaminophen
(therapeutic use)
- Adrenergic Uptake Inhibitors
(therapeutic use)
- Analgesics, Non-Narcotic
(therapeutic use)
- Analgesics, Opioid
(therapeutic use)
- Anti-Inflammatory Agents, Non-Steroidal
(therapeutic use)
- Codeine
(therapeutic use)
- Drug Combinations
- Drug Evaluation
- Facial Pain
(drug therapy)
- Humans
- Pain, Postoperative
(drug therapy)
- Tramadol
(therapeutic use)
|